Bullboard - Stock Discussion Forum Sonnet Biotherapeutics Holdings Inc SONN

Consumer Cyclical Biotechnology

Sonnet BioTherapeutics Holdings, Inc. is a clinical-stage, oncology-focused biotechnology company with a proprietary platform for biologic medicines of single-or bifunctional action. Its technology, namely Fully Human Albumin Binding (FHAB), utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. It designed the... see more

Add To Watchlist

NDAQ:SONN - Post Discussion

Sonnet Biotherapeutics Holdings Inc > Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 202

View:

Post by whytestocks on Aug 14, 2024 1:32pm

Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 202

JUST IN: $SONN Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateOngoing progress with both clinical trials of lead program, SON-1010, for solid tumors and Platinum-Resistant Ovarian Cancer (PROC) Partnership efforts to support initiation of a Phase 2 clinical trial of SON-080 in Diabetic Peripheral Neuropathy (DPN) underway Granted compositi...SONN - Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

401